Genome research: fulfilling the public's expectations for knowledge and commercialization
1National Institutes of Health, Bethesda, MD 20892.
Science (New York, N.Y.)
|August 14, 1992
Summary
This article examines gene sequence patenting, exploring patent law evolution and its effects on academic research and technology transfer. Careful policy adoption is crucial for genome research amidst rapid technological advancements.
Area of Science:
- Biotechnology Law
- Intellectual Property
- Genomic Research
Background:
- Historical context of gene sequence patenting.
- Fundamentals and evolution of patent law.
- Overview of federal technology transfer law and policy.
Purpose of the Study:
- Assess the impact of gene patenting on academic research.
- Examine the patentability of gene sequences.
- Analyze the influence of published sequence data on downstream product patent protection.
Main Methods:
- Historical analysis of patent law.
- Review of federal technology transfer policies.
- Examination of industry perspectives and public records on gene patenting.
Main Results:
- Gene patenting has evolved significantly, impacting academic research and technology transfer.
- Patentability of gene sequences presents complex challenges, especially with published data.
- Industry and public perspectives highlight the need for careful policy development.
Conclusions:
- Technology transfer policies for genome research require careful, adaptable implementation.
- Balancing innovation with access is key in the evolving landscape of gene patenting.
- Strategic patent application and licensing are critical for genomic advancements.
Related Concept Videos
00:58Genomic DNA in Eukaryotes
Eukaryotes have large genomes compared to prokaryotes. To fit their genomes into a cell, eukaryotic DNA is packaged extraordinarily tightly inside the nucleus. To achieve this, DNA is tightly wound around proteins called histones, which are packaged into nucleosomes that are joined by linker DNA and coil into chromatin fibers. Additional fibrous proteins further compact the chromatin, which is recognizable as chromosomes during certain phases of cell division.
02:02Genomics
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
02:34DNA Microarrays
Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
01:20The Central Dogma
The central dogma explains the flow of genetic information from DNA nucleotides to the amino acid sequence of proteins.
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...